For the second time in 16 months, Unity Biotechnology is restructuring its operations. The developer of drugs to treat diseases of aging is cutting its headcount in half to ensure its cash reserves ...
Unity has promoted its senior VP of corporate development Alex Blum to the position of chief operating officer. His appointment is effective from November 1st, 2024. Blum joined Unity in July 2024 and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback